Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
12.39
+0.17 (1.39%)
At close: Sep 8, 2026, 4:00 PM EDT
12.50
+0.28 (2.29%)
Pre-market: Sep 9, 2026, 8:07 AM EDT
Cybin Employees
Cybin had 100 employees as of March 31, 2026. The number of employees increased by 50 or 100.00% compared to the previous year.
Employees
100
Change (1Y)
50
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,712,040
Market Cap
905.22M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 50 | 100.00% |
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Rigel Pharmaceuticals | 174 |
| Olema Pharmaceuticals | 150 |
| Annexon | 92 |
| Theravance Biopharma | 90 |
| Aclaris Therapeutics | 73 |
| Crescent Biopharma | 69 |
| Design Therapeutics | 55 |
HELP News
- 59 minutes ago - Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York - GlobeNewsWire
- 6 days ago - Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York - GlobeNewsWire
- 20 days ago - Helus Pharma price target raised to $62 from $8 at TD Cowen - TheFly
- 22 days ago - Helus Pharma appoints Regina Donohue as chief people officer - TheFly
- 22 days ago - Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board - GlobeNewsWire
- 25 days ago - Cybin Earnings release: Q1 2027 - Filings
- 26 days ago - Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights - GlobeNewsWire
- 27 days ago - Cybin Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts